HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Buoyed By Emerging Markets, Dove Global Sales

This article was originally published in The Rose Sheet

Executive Summary

Unilever is “the emerging-market consumer goods company,” CEO Paul Polman suggests, as the firm derived more than 55% of its first-half turnover from emerging markets. Meanwhile, Dove sales exceeded €3 billion ($3.79 billion), dispelling any notion that the brand could be a curse rather than a strength, Polman says.

You may also be interested in...



With Kalina Acquisition, Unilever Becomes Skin-Care Leader In Russia

Unilever’s acquisition of Ekaterinburg, Russia-based Concern Kalina will bolster the firm’s personal-care positioning in Russia, making it one of the market leaders in a locale where it previously struggled.

Euromonitor: Value Shopping, Gender-Blurring Among Top Consumer Trends For 2106

A new report from market-research firm Euromonitor International suggests that global consumption in the coming year will see a blend of established, new and counter trends, challenging the way consumers live and shop. Within beauty, marketers may seize on the trends of value shopping, gender-blurring and embracing of aging to reach discriminating consumers in 2016.

P&G Eyes Product Sampling, Trials As Fix For Sagging Sales

Procter & Gamble management highlights product sampling and trials as opportunities to drive home product benefits with consumers at a time when the firm is increasing prices to counter the currency impact of the strong dollar. Analysts pressured P&G CFO Jon Moeller for details on the firm's turnaround following a troublesome quarter.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018213

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel